Inoue K et al. |
Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. |
2006 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17008592
|
Nordén R et al. |
Inhibition of protein deacetylation augments herpes simplex virus type 1-activated transcription of host fucosyltransferase genes associated with virus-induced sLex expression. |
2010 |
Arch. Virol. |
pmid:20039087
|
Shinde V et al. |
Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Tox and STOP-Tox tests. |
2017 |
Arch. Toxicol. |
pmid:27188386
|
Pallocca G et al. |
Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. |
2016 |
Arch. Toxicol. |
pmid:26705709
|
Rempel E et al. |
A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. |
2015 |
Arch. Toxicol. |
pmid:26272509
|
Balmer NV et al. |
From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. |
2014 |
Arch. Toxicol. |
pmid:24935251
|
Zapletal O et al. |
Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. |
2017 |
Arch. Toxicol. |
pmid:27830268
|
Cipriano M et al. |
The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. |
2017 |
Arch. Toxicol. |
pmid:27909741
|
Lu MC et al. |
Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. |
2009 |
Arch. Toxicol. |
pmid:18709356
|
Ahn MR et al. |
Trichostatin A, a histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in Hepa-I cells. |
2004 |
Arch. Pharm. Res. |
pmid:15180307
|
Han SB and Lee JK |
Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. |
2009 |
Arch. Pharm. Res. |
pmid:19407980
|
Kim SN et al. |
Regulation of adipocyte differentiation by histone deacetylase inhibitors. |
2009 |
Arch. Pharm. Res. |
pmid:19407971
|
Joung KE et al. |
Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15283467
|
Min KN et al. |
Estrogen receptor enhances the antiproliferative effects of trichostatin A and HC-toxin in human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15202563
|
Schmidt K et al. |
Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. |
1999 |
Arch. Pharm. (Weinheim) |
pmid:10575368
|
Cunneen TS et al. |
In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. |
2009 |
Arch. Ophthalmol. |
pmid:19365017
|
Piotrowska H and Jagodzinski PP |
Glucocorticoid receptor alpha and beta variant expression is associated with ASF/SF2 splicing factor upregulation in HT-29 colon cancer and MCF-7 breast carcinoma cells. |
2009 |
Arch. Med. Res. |
pmid:19427965
|
Hou SY et al. |
Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism. |
2014 |
Arch. Med. Res. |
pmid:24316396
|
Yu L et al. |
Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. |
2012 |
Arch. Med. Res. |
pmid:22564421
|
Royce SG et al. |
Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. |
2012 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:22684086
|